Literature DB >> 164617

Selective inhibition of the replication of herpes simplex virus by 5-halogenated analogues of deoxycytidine.

I Schildkraut, G M Cooper, S Greer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164617

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  13 in total

1.  Physical mapping of herpes simplex virus type 1 mutations by marker rescue.

Authors:  N D Stow; J H Subak-Sharpe; N M Wilkie
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

2.  5-Propyl-2'-deoxyuridine: a specific anti-herpes agent.

Authors:  E De Clercq; J Descamps; D Shugar
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

Review 3.  Specific targets for antiviral drugs.

Authors:  E De Clercq
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

4.  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Authors:  P A Furman; M H St Clair; J A Fyfe; J L Rideout; P M Keller; G B Elion
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

5.  Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.

Authors:  C Shipman; S H Smith; R H Carlson; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

6.  Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.

Authors:  L M Fox; J A Mekras; C B Bagwell; S B Greer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

7.  Synthesis and biological properties of 2'-deoxy-5-vinyluridine and 2'deoxy-5-vinylcytidine.

Authors:  S G Rahim; M J Duggan; R T Walker; A S Jones; R L Dyer; J Balzarini; E De Clercq
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

8.  Acyclovir inhibition of Epstein-Barr virus replication.

Authors:  A K Datta; B M Colby; J E Shaw; J S Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  N-Mannich-base prodrugs of 5-iodo-2'-deoxycytidine as topical delivery enhancers.

Authors:  S A Koch; K B Sloan
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

10.  Enzymatic basis for the selective inhibition of varicella-zoster virus by 5-halogenated analogues of deoxycytidine.

Authors:  M J Dobersen; M Jerkofsky; S Greer
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.